Purpose interaction safety studies in rats and dogs, period of performance: 03/25/2020-03/24/2021. Nida REF. No. N01DA-18-8939. FY20
Ended Awarded Last action
- Contract number
- 75N95020F00001
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,206,338
Award facts
- Opportunity
-
- Toxicological Evaluations of Potential Medications Pre-Solicitation · Posted Dec 4, 2017
- Contract value 100% obligated
- $1,206,338.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $76,200 | |
| Change Order | $17,046 | |
| Other Administrative Action | $0 | |
| Original award | $1,113,092 |
About this award
This is a cost-plus-fixed-fee delivery order contract awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) to SRI International, a nonprofit research and development institute. The purpose of the contract is to conduct purpose interaction safety studies in rats and dogs, with a period of performance from March 25, 2020 to March 24, 2021. The total potential value of the contract is $1,206,338.00. The contract is part of NIDA's Major Program Code for Toxicological Evaluations of Potential Medications and does not have a set-aside designation. SRI International has conducted substantial research and development work for various federal agencies, including the Department of Defense, NASA, and HHS components.
Quick answers
Who was awarded contract 75N95020F00001?
75N95020F00001 was awarded to Sri International by National Institute on Drug Abuse (National Institutes of Health) on March 25, 2020.
How much is contract 75N95020F00001 worth?
The government has obligated $1,206,338 on 75N95020F00001.
Is contract 75N95020F00001 an order under another contract?
Yes. 75N95020F00001 is a delivery order under 75N95018G00019, a basic ordering agreement.
Was contract 75N95020F00001 competed?
The extent of competition for 75N95020F00001 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award